Agilent Technologies Inc.
Agilent Technologies Declassifies Board Over Three Years
Summary
Agilent Technologies, Inc. held its Annual Meeting on March 18, 2026, where stockholders approved the adoption of the Fourth Amended and Restated Certificate of Incorporation and Bylaws. The new Certificate of Incorporation provides for the declassification of the Board over a three-year period, while the Bylaws amend and restate the Prior Bylaws to reflect this change and allow for the removal of a director with or without cause from the 2029 annual meeting of stockholders. The voting results showed strong support for the election of directors and other proposals.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement